Acronym |
Definition |
ACCHS |
Aboriginal Community Controlled Health Service |
AGPS |
Australian Government Publishing Service |
AHW |
Aboriginal Health Worker |
AIDS |
acquired immune deficiency syndrome |
ALT |
alanine transaminase |
ANCA |
Australian National Council on AIDS |
ATSI |
Aboriginal and Torres Strait Islander
|
BBV |
blood-borne virus |
CARPA |
Central Australian Rural Practitioners’ Association |
CD4+ T LYMPHOCYTE |
special type of lymphocyte |
CDCD |
Communicable Disease Control Directorate |
CIN |
cervical intra-epithelial neoplasia |
CMW |
cytomegalovirus |
CO2 |
carbon dioxide |
CRF |
circulating recombinant form |
CSF |
cerebrospinal fluid |
DNA |
deoxyribonucleic acid |
DOT |
directly observed therapy |
ECS |
endocervical swab |
EIA |
enzyme immunoassay |
ESR |
erythrocyte sedimentation rate |
FVU |
first void urine |
FTA-ABS |
fluorescent treponemal antibody absorption test |
GNID |
Gram-negative intracellular diplococci |
GUD |
genital ulcer disease |
HAND |
HIV-associated neurocognitive disorder |
HAV |
hepatitis A virus |
HBIG |
hepatitis B immunoglobin |
HBV |
hepatitis B virus |
HCV |
hepatitis C virus |
HIV |
human immunodeficiency virus |
HPF |
high-powered field |
HPV |
human papillomavirus |
HRT |
hormone replacement therapy |
HSV |
herpes simplex virus |
IDU |
injecting drug user |
IGG |
immunoglobulin G |
IGM |
immunoglobulin M |
IMI |
intramuscular injection |
IU |
international unit |
IUD |
intra-uterine device |
LCR |
ligase chain reaction |
LGV |
lymphogranuloma venereum |
LGV-CFT |
lymphogranuloma venereum complement fixation test |
MACBBVS |
Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmissible Infections |
MC&S |
microscopy, culture and sensitivity testing |
MSM |
men who have sex with men |
N2O |
nitrous oxide |
NAAT |
nucleic acid amplification test |
NGU |
non-gonococcal urethritis |
NHIG |
normal human immunoglobulin |
NHMRC |
National Health and Medical Research Council |
NPEP |
non-occupational post-exposure prophylaxis |
NSU |
non-specific urethritis |
PAP SMEAR |
Papanicolaou smear |
PBS |
Pharmaceutical Benefits Scheme |
PCR |
polymerase chain reaction |
PEP |
post-exposure prophylaxis |
PHU |
population/public health unit |
PID |
pelvic inflammatory disease |
RNA |
ribonucleic acid |
RPR |
rapid plasma reagin test |
SARC |
Sexual Assault Resource Centre |
SOLVS |
self-obtained low vaginal swab |
SOPV |
sex-on-premises venue |
STD |
sexually transmitted disease |
STI |
sexually transmitted infection |
TPHA |
Treponema pallidum haemagglutination test |
TPPA |
Treponema pallidum particle agglutination test |
UTI |
urinary tract infection |
VDRL |
Venereal Disease Research Laboratory test |
WA |
Western Australia |
WA HEALTH |
Western Australian Department of Health |
WANIDD |
Western Australian Notifiable Infectious Diseases Database |
WBC |
white blood cells |
WHO |
World Health Organization |